Regeneron Pharmaceuticals REGN spent $430K on lobbying in Q1 2024 · Medicare, Copyright and 1 more issue

Trade details

Type: Lobbying report
Amount: $430,000
Quarter: Q1 2024
Stock: Regeneron Pharmaceuticals REGN
Client: Regeneron Pharmaceuticals
Reported: 24/04/22

Up 0.0% from last quarter

What else happened in Regeneron Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/03/01~24/04/30

Regeneron Pharmaceuticals's other lobbying reports

Regeneron Pharmaceuticals
LobbyingRegeneron Pharmaceuticals
Lobbying
Regeneron Pharmaceuticals
REGN
$50K
$50K
Reported 08/03
for Q2
Regeneron Pharmaceuticals
LobbyingRegeneron Pharmaceuticals
Lobbying
Regeneron Pharmaceuticals
REGN
$630K
$630K
Reported 07/20
for Q2
Regeneron Pharmaceuticals
LobbyingRegeneron Pharmaceuticals
Lobbying
Regeneron Pharmaceuticals
REGN
$50K
$50K
Reported 07/20
for Q2
Regeneron Pharmaceuticals
LobbyingRegeneron Pharmaceuticals
Lobbying
Regeneron Pharmaceuticals
REGN
$90K
$90K
Reported 07/20
for Q2
Regeneron Pharmaceuticals
LobbyingRegeneron Pharmaceuticals
Lobbying
Regeneron Pharmaceuticals
REGN
$90K
$90K
Reported 07/15
for Q2

Regeneron Pharmaceuticals REGN spent $430K on lobbying in Q1 2024 · Medicare, Copyright and 1 more issue | Whalegun